Our latest Product Manager comes from Cell Imaging Core facility Turku New Product Manager in our microscopy team – Markku Saari: I´m highly excited to…
News
Meet Mica – The world’s first Microhub
Access for all – No constraints – Radically simplified workflows Meet Mica at Leica Virtual Campus (live demos, materials and recordings) Meet Mica here…
Accelerate your microbiome studies with us!
The microbiome is a fascinating and rapidly growing field of study. Complex microbial communities, whether in the air, water, soil, plants, or symbiosis with humans,…
Do you want to analyze RNA kinetics & metabolism in your cells?
Access RNA kinetics within cultured cells! Much easier than e.g. GRO-seq To measure RNA kinetics, which transcripts are newly synthetized (nascent) and which are degraded,…
Assay Kits for your apoptosis research – Autumn offer!
Advantage of Elabscience® TUNEL Kits Multiple Choices: FITC, AF488, AF594, EV450, F647, AF555 Quick & Simple Operation: One-step method, only 3 hours (for frozen…
Multiplexed Imaging Solution Cell DIVE now from Immuno Diagnostic!
Multiplexed Imaging Solution Cell DIVE A hyperplexed imaging technique delivering spatial biomarker mapping Cell DIVE multiplexed imaging is an antibody-based hyperplexed technique addressing spatial cell…
Our new supplier for NGS, cytogenomics, synthetic biology: Daicel Arbor Biosciences
Daicel Arbor Biosciences Daicel Arbor Biosciences (Ann Arbor, MI, USA) offers high-quality and cost-efficient solutions for 1. Genomics – NGS Targeted sequencing – Hybridization capture…
Custom NGS Amplicon panels – made ready for you!
Do you want to detect and sequence specific genes, variants or gene fusions? Custom NGS Amplicon Panels from Paragon Genomics. Just create the list of…
Immuno Diagnostic Oy appoints a new CEO
Tomi Virtanen will begin as the new CEO of Immuno Diagnostic Oy Our current CEO Jarmo Laakkonen has decided to pursue other endeavors and as…
How does the T-SPOT.COVID test perform against serology?
In a study of 151 individuals, the T-SPOT.COVID test identified 51% more individuals with a previous positive COVID-19 PCR test result than a leading serology…